AzTrials
AzTrials

Difficult AirwayNCT06626204

Exploration and Application of Intelligent Difficult Airway Assessment Scheme

An observational study of Difficult Airway, run by Min Su at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to explore the effectiveness of an intelligent difficult airway assessment protocol and its potential in clinical applications. The management of difficult airways is a critical task in anesthesiology, and poor management can lead to severe complications or even death. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Difficult Airway
How many people
475 participants
Where
1 siteChina
Study dates
23 Sep 2024to 10 Jan 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients scheduled for elective general anesthesia with endotracheal intubation.

Who may be able to join

  • Age ≥18 years, with no gender restrictions;
  • Subjects who are scheduled to undergo elective general anesthesia and require endotracheal intubation;
  • Subjects classified as American Society of Anesthesiologists Physical Status (ASA-PS) Class I, II, and III;
  • Volunteers who are willing to participate in this clinical trial and have signed the Informed Consent Form.

Who cannot join

  • Subjects with known airway deformities, tumors, or other structural abnormalities that may affect airway assessment;
  • Subjects with psychiatric disorders or other conditions that prevent cooperation;
  • Pregnant or lactating women;
  • Subjects who have participated in other interventional clinical trials within 1 month prior to the start of this trial;
  • Subjects deemed inappropriate to participate in this clinical trial by the investigator.

Trial locations and contacts

1 site in 1 country.

China1 site
  • First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400016

Other trials in China

About this study

The study aims to explore the effectiveness of an intelligent difficult airway assessment protocol and its potential in clinical applications. The management of difficult airways is a critical task in anesthesiology, and poor management can lead to severe complications or even death. The American Society of Anesthesiologists defines a difficult airway as one that presents difficulties in mask ventilation or endotracheal intubation. Previous studies have shown that the incidence of difficult airways is not low in patients undergoing general anesthesia, emphasizing the need for optimization of airway management strategies.

Preoperative airway assessment is an essential step in preventing complications associated with difficult airways. Currently, the modified Mallampati classification and the Cormack-Lehane grading are two commonly used assessment tools. However, these methods rely on the subjective judgment of clinicians and may have limitations in accuracy and consistency. With the development of artificial intelligence and telemedicine technologies, new assessment methods have become possible, offering more precise measurements and analysis of airway anatomy.

Read more

This study proposes an intelligent airway assessment system that combines phonation modulation and tongue position adjustment, aiming to improve the accuracy and reliability of assessments. The system uses deep learning algorithms to analyze oral images of subjects to predict airway difficulty. The study will also explore the correlation of this system with traditional assessment methods and establish a predictive model for difficult airways.

As a country with a large population, China has a significant demand for medical and health resources, especially in the fields of surgery and anesthesia. The diversity of China's population may affect airway structure, thereby influencing airway management strategies. Therefore, conducting such research in China has important clinical significance and social value.

Read the detailed description

The research background is based on a critical issue in anesthetic practice - the management of difficult airways. A difficult airway refers to the challenges encountered during mask ventilation or endotracheal intubation, which can lead to severe complications or even death. The American Society of Anesthesiologists (ASA) defines a difficult airway as one that presents difficulties in mask ventilation, laryngoscopy, use of supraglottic airway devices, endotracheal intubation, extubation, or invasive airway access, including but not limited to situations that are anticipated or unanticipated. Studies have shown that the incidence of difficult and unventilatable mask airways in the general subject population is 2.2% and 0.15%, respectively, while the rate of difficult or failed intubation in general anesthesia events is between 0.43% and 0.52%. These data highlight the importance of accurate airway assessment before anesthesia.

In China, due to the large population, there is a significant demand for medical and health resources, especially in the fields of surgery and anesthesia. The diversity of China's population, including regional, ethnic, and genetic background differences, may affect airway structure, thereby influencing airway management strategies. Therefore, conducting research on the assessment and management of difficult airways in China has important clinical and social significance.

Preoperative airway assessment is a key step in preventing complications associated with difficult airways. Currently, the modified Mallampati classification and the Cormack-Lehane grading are commonly used assessment tools in clinical practice. The modified Mallampati classification assesses the difficulty of the airway by observing the visibility of structures within the oral cavity, while the Cormack-Lehane grading assesses it through the visibility of laryngeal structures during direct laryngoscopy. Although these methods are widely used in clinical practice, they have issues with subjectivity, poor repeatability, and limited accuracy.

With the advancement of medical technology, especially the rapid development of artificial intelligence (AI) and telemedicine, new opportunities have emerged to improve the assessment methods for difficult airways. The use of intelligent devices and algorithms can provide more precise measurements and analysis of the subject's airway anatomy, thereby improving the accuracy and reliability of the assessment. This new method not only reduces the interference of subjectivity but also improves the repeatability of the assessment through standardized image collection and analysis processes.

This study proposes an intelligent airway assessment system that combines phonation modulation and tongue position adjustment, aiming to improve the accuracy and reliability of assessments. The system uses deep learning algorithms to analyze oral images of subjects to predict airway difficulty. The study will also explore the correlation of this system with traditional assessment methods and establish a predictive model for difficult airways.

The clinical significance of the study lies in the fact that, with more accurate airway assessment, anesthesiologists can take appropriate preventive measures and strategies in advance, reducing complications due to improper airway management, such as hypoxia, failed intubation, etc. This will directly improve surgical safety, reduce the postoperative recovery time and medical costs for subjects. In addition, the results of the study may also provide new theoretical bases and practical guidelines for the field of airway assessment, promoting the development and innovation of related technologies and methods.

The social value of conducting such research in China is that, with the trend of digital transformation in the medical industry, the application of intelligent airway assessment methods helps to improve overall medical efficiency and subject safety. In areas with limited resources or remote geographical locations, doctors can use remote connections and intelligent devices to assess the airways of subjects, achieving high-quality medical services.

Keywords
Difficult Airway, artificial intelligence, Modified Mallampati Classification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between intelligent airway assessment and modification of Mallampati classification and Cormack-Lehane grading.

    Measured: From enrollment to one day after extubation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2024
  2. Study start23 Sep 2024
  3. Primary completion10 Jan 2025
  4. Study completion10 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
475 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06626204
Sponsor's protocol ID
202409701
Status last verified
Feb 2026
First submitted
2 Oct 2024
Last updated
18 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Difficult Airway, run by Min Su at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between intelligent airway assessment and modification of Mallampati classification and Cormack-Lehane grading. (time frame: From enrollment to one day after extubation.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in